The Role of Post-treatment FDG-PET/CT Scanning after the First-line Chemotherapy in Predicting Prognosis in Patients with Hodgkin Disease and High-grade Non-Hodgkin Lymphoma: A Comparative Study with Clinical Prognostic Risk Scoring Data

---

ERDOĞAN E. B., Guner S., SÖNMEZOĞLU K.

BEZMIALEM SCIENCE, cilt.10, sa.3, ss.264-273, 2022 (ESCI)

• Yayın Türü: Makale / Tam Makale
• Cilt numarası: 10 Sayı: 3
• Basım Tarihi: 2022
• Doi Numarası: 10.14235/bas.galenos.2021.5981
• Dergi Adı: BEZMIALEM SCIENCE
• Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), TR DİZİN (ULAKBİM)
• Sayfa Sayıları: ss.264-273
• Anahtar Kelimeler: Lymphoma, positron emission mography/computed tomography, F-18 fluorodeoxyglucose, clinical prognostic risk scores, POSITRON-EMISSION-TOMOGRAPHY, B-CELL LYMPHOMA, SUV-BASED ASSESSMENT, RESPONSE ASSESSMENT, F-18-FDG PET
• Açık Arşiv Koleksiyonu: AVESİS Açık Erişim Koleksiyonu
• İstanbul Üniversitesi Adresli: Hayır

Özet

Objective: We aimed to evaluate the role of fluorodeoxyglucose (FDG)-positron emission tomography/computed tomography (PET/CT) performed after the first-line therapy in predicting prognosis of lymphomas and compare the results with the pretreatment prognostic risk scoring (PRS) indices.